FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

3930911000001108: Orelox 40mg/5ml paediatric oral suspension (Aventis Pharma) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
18051501000001116 Orelox 40mg/5ml paediatric oral suspension (Aventis Pharma) (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
65945601000001112 Orelox 40mg/5ml oral suspension paediatric (Sanofi) en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Orelox 40mg/5ml paediatric oral suspension (Aventis Pharma) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Orelox 40mg/5ml paediatric oral suspension (Aventis Pharma) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Orelox 40mg/5ml paediatric oral suspension (Aventis Pharma) Is a Cefpodoxime 40mg/5mL pediatric suspension false Inferred relationship Existential restriction modifier
Orelox 40mg/5ml paediatric oral suspension (Aventis Pharma) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available true Inferred relationship Existential restriction modifier
Orelox 40mg/5ml paediatric oral suspension (Aventis Pharma) Has excipient Aspartame false Inferred relationship Existential restriction modifier
Orelox 40mg/5ml paediatric oral suspension (Aventis Pharma) Has active ingredient Bactericide false Inferred relationship Existential restriction modifier
Orelox 40mg/5ml paediatric oral suspension (Aventis Pharma) Has active ingredient Cefpodoxime proxetil true Inferred relationship Existential restriction modifier
Orelox 40mg/5ml paediatric oral suspension (Aventis Pharma) Has active ingredient Cefpodoxime false Inferred relationship Existential restriction modifier
Orelox 40mg/5ml paediatric oral suspension (Aventis Pharma) Has excipient Lactose false Inferred relationship Existential restriction modifier
Orelox 40mg/5ml paediatric oral suspension (Aventis Pharma) Has active ingredient Substance with antibacterial mechanism of action false Inferred relationship Existential restriction modifier
Orelox 40mg/5ml paediatric oral suspension (Aventis Pharma) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Orelox 40mg/5ml paediatric oral suspension (Aventis Pharma) VMP non-availability indicator Available false Inferred relationship Existential restriction modifier
Orelox 40mg/5ml paediatric oral suspension (Aventis Pharma) Has manufactured dose form Conventional release oral suspension true Inferred relationship Existential restriction modifier
Orelox 40mg/5ml paediatric oral suspension (Aventis Pharma) Is a Orelox true Inferred relationship Existential restriction modifier
Orelox 40mg/5ml paediatric oral suspension (Aventis Pharma) Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Cefpodoxime true Inferred relationship Existential restriction modifier
Orelox 40mg/5ml paediatric oral suspension (Aventis Pharma) Has specific active ingredient Cefpodoxime proxetil true Inferred relationship Existential restriction modifier
Orelox 40mg/5ml paediatric oral suspension (Aventis Pharma) Has dispensed dose form Conventional release oral suspension true Inferred relationship Existential restriction modifier
Orelox 40mg/5ml paediatric oral suspension (Aventis Pharma) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Orelox 40mg/5ml paediatric oral suspension (Aventis Pharma) VMP non-availability indicator Not available true Inferred relationship Existential restriction modifier
Orelox 40mg/5ml paediatric oral suspension (Aventis Pharma) Has basis of strength substance Cefpodoxime true Inferred relationship Existential restriction modifier
Orelox 40mg/5ml paediatric oral suspension (Aventis Pharma) Is a Cefpodoxime 40mg/5ml oral suspension false Inferred relationship Existential restriction modifier
Orelox 40mg/5ml paediatric oral suspension (Aventis Pharma) Is a Cefpodoxime 40mg/5ml oral suspension true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Orelox 40mg/5ml paediatric oral suspension (Aventis Pharma) 50 ml Is pack of False Orelox 40mg/5ml paediatric oral suspension (Aventis Pharma) Inferred relationship Existential restriction modifier
Orelox 40mg/5ml paediatric oral suspension (Aventis Pharma) 100 ml Is pack of False Orelox 40mg/5ml paediatric oral suspension (Aventis Pharma) Inferred relationship Existential restriction modifier
Orelox 40mg/5ml paediatric oral suspension (Aventis Pharma) 100 ml Has AMP True Orelox 40mg/5ml paediatric oral suspension (Aventis Pharma) Inferred relationship Existential restriction modifier
Orelox 40mg/5ml paediatric oral suspension (Aventis Pharma) 50 ml Has AMP True Orelox 40mg/5ml paediatric oral suspension (Aventis Pharma) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start